Total Payments
$8,465
2024 Payments
$1,234
Companies
35
Transactions
505
Medicare Patients
10,034
Medicare Billing
$934,955
Payment Breakdown by Category
Food & Beverage$8,393 (99.1%)
Education$72.11 (0.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,393 | 499 | 99.1% |
| Education | $72.11 | 6 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $1,023 | 65 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,017 | 54 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $774.45 | 47 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $728.09 | 40 | $0 (2024) |
| Novo Nordisk Inc | $629.58 | 44 | $0 (2024) |
| ABBVIE INC. | $610.92 | 41 | $0 (2024) |
| PFIZER INC. | $453.71 | 24 | $0 (2024) |
| Amgen Inc. | $423.46 | 25 | $0 (2024) |
| Merck Sharp & Dohme LLC | $419.28 | 31 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $384.87 | 25 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,234 | 68 | Lilly USA, LLC ($239.79) |
| 2023 | $1,219 | 69 | GlaxoSmithKline, LLC. ($276.20) |
| 2022 | $1,267 | 76 | Bayer HealthCare Pharmaceuticals Inc. ($271.42) |
| 2021 | $989.51 | 50 | AbbVie Inc. ($232.13) |
| 2020 | $827.51 | 53 | AstraZeneca Pharmaceuticals LP ($134.42) |
| 2019 | $170.97 | 10 | AstraZeneca Pharmaceuticals LP ($85.23) |
| 2018 | $570.81 | 39 | SANOFI-AVENTIS U.S. LLC ($112.78) |
| 2017 | $2,187 | 140 | GlaxoSmithKline, LLC. ($278.17) |
All Payment Transactions
505 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 12/04/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: Inflammation | ||||||
| 11/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: DIABETES | ||||||
| 11/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Cardio-renal | ||||||
| 11/18/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: VACCINES | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: Respiratory | ||||||
| 10/30/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $12.66 | General |
| Category: Cardio-renal | ||||||
| 10/29/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Merck Sharp & Dohme LLC | LAGEVRIO (Drug) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $29.97 | General |
| Category: DIABETES | ||||||
| 10/14/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: VACCINES | ||||||
| 10/01/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: Diabetes | ||||||
| 09/25/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $5.29 | General |
| Category: Diabetes | ||||||
| 09/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $12.27 | General |
| Category: Cardio-renal | ||||||
| 09/17/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: Inflammation | ||||||
| 08/21/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $21.26 | General |
| 08/12/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: Diabetes | ||||||
| 08/07/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: Cardio-renal | ||||||
| 08/06/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Inflammation | ||||||
| 07/24/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: Biological | ||||||
| 07/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: Cardio-renal | ||||||
| 07/08/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: Respiratory | ||||||
| 07/01/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 2,494 | 3,631 | $919,729 | $286,355 |
| 2022 | 20 | 2,471 | 3,513 | $837,170 | $245,569 |
| 2021 | 21 | 2,378 | 3,134 | $661,222 | $217,431 |
| 2020 | 23 | 2,691 | 3,833 | $391,109 | $185,600 |
Total Patients
10,034
Total Services
14,111
Medicare Billing
$934,955
Procedure Codes
81
All Medicare Procedures & Services
81 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 521 | 1,316 | $381,640 | $100,635 | 26.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 279 | 411 | $176,730 | $46,851 | 26.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 142 | 142 | $49,700 | $39,776 | 80.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 251 | 251 | $117,970 | $38,265 | 32.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 203 | 203 | $23,345 | $15,389 | 65.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 138 | 197 | $43,352 | $14,932 | 34.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 249 | 251 | $20,080 | $9,031 | 45.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 142 | 142 | $7,668 | $5,109 | 66.6% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 37 | 40 | $12,405 | $4,547 | 36.7% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 17 | 17 | $11,220 | $3,325 | 29.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 242 | 265 | $31,800 | $3,089 | 9.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 41 | 41 | $4,528 | $2,936 | 64.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 17 | 72 | $33,535 | $899.14 | 2.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 14 | 14 | $2,520 | $758.38 | 30.1% |
| 81002 | Urinalysis, manual test | Office | 2023 | 108 | 118 | $1,770 | $402.38 | 22.7% |
| 82272 | Stool analysis for blood, by peroxidase activity | Office | 2023 | 76 | 79 | $1,185 | $327.85 | 27.7% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 17 | 72 | $280.80 | $82.58 | 29.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 508 | 1,220 | $353,800 | $92,978 | 26.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 312 | 446 | $190,660 | $46,316 | 24.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 261 | 261 | $122,670 | $40,928 | 33.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 229 | 229 | $20,610 | $16,087 | 78.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 124 | 181 | $36,200 | $13,209 | 36.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 284 | 289 | $23,120 | $10,203 | 44.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 23 | 23 | $8,050 | $6,131 | 76.2% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 34 | 34 | $9,690 | $3,633 | 37.5% |
About Robert Fulop
Robert Fulop is a Internal Medicine healthcare provider based in Staten Island, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1861461345.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Robert Fulop has received a total of $8,465 in payments from pharmaceutical and medical device companies, with $1,234 received in 2024. These payments were reported across 505 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($8,393).
As a Medicare-enrolled provider, Fulop has provided services to 10,034 Medicare beneficiaries, totaling 14,111 services with total Medicare billing of $934,955. Data is available for 4 years (2020–2023), covering 81 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Staten Island, NY
- Active Since 03/16/2006
- Last Updated 07/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1861461345
Products in Payments
- Kerendia (Drug) $728.09
- TRELEGY ELLIPTA (Drug) $583.70
- TRULICITY (Drug) $511.80
- FARXIGA (Drug) $443.70
- JARDIANCE (Drug) $364.57
- Rybelsus (Drug) $249.23
- Victoza (Drug) $232.09
- JANUVIA (Drug) $227.70
- MOUNJARO (Drug) $227.22
- Livalo (Drug) $223.76
- VRAYLAR (Drug) $190.57
- TOUJEO (Drug) $184.61
- Signia (Device) $174.88
- ELIQUIS (Drug) $174.79
- AIRSUPRA (Drug) $174.68
- XARELTO (Drug) $171.68
- SYNTHROID (Drug) $164.02
- BREO (Drug) $161.97
- UBRELVY (Drug) $161.11
- Vascepa (Drug) $148.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Staten Island
Dr. Seth Brum, M.d, M.D
Internal Medicine — Payments: $409,260
Internal Medicine $409,260
Dr. Maryann Lee, M.d, M.D
Internal Medicine — Payments: $115,406
Internal Medicine $115,406
Dr. Alexander Beylinson, D.o, D.O
Internal Medicine — Payments: $61,903
Internal Medicine $61,903
Dr. Miguel Tirado, M.d, M.D
Internal Medicine — Payments: $35,111
Internal Medicine $35,111
Dr. Alan Dunton, M.d, M.D
Internal Medicine — Payments: $34,946
Internal Medicine $34,946
Dr. John Zafaranloo, M.d, M.D
Internal Medicine — Payments: $29,178
Internal Medicine $29,178